Pharmaceutical Executive September 24, 2024
The latest news for pharma industry insiders.
The Financial Benefits of Technology
In the final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, explains the amount of time it takes to see a reduction in annualized drug spend, and offers estimates in terms of percent savings.
What Diabetes Taught Me That Pharmacy School Did Not
Empathy is being left outside the exam room door.
Will A.I. Be a Bust? A Wall Street Skeptic Rings the Alarm.
Jim Covello, Goldman Sachs’s head of stock research, warned that building too much of what the world doesn’t need “typically ends badly.”
Kenvue Drives Climate Action Strategy Forward
Kenvue Inc., the maker of...